Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients

doi:10.4254/wjh.v17.i8.107456

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (361)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-4)

Sum=174

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

125

Sum=177

Aug 27, 2025 (publication date) through Aug 30, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Aug 27, 2025; 17(8): 107456
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.107456

Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients

Lan-Lan Si, Zhen-Ping Fan, Wen-Hui Liu, Rong-Juan Chen, Xue-Yuan Chen, Dong Ji, Le Li, Chun Chen, Hao Liao, Jun Wang, Dong-Ping Xu, Jun Zhao, Yan Liu

Lan-Lan Si, Graduate School, Guangzhou Medical University, Guangzhou 511436, Guangdong Province, China

Lan-Lan Si, Rong-Juan Chen, Xue-Yuan Chen, Le Li, Hao Liao, Jun Wang, Dong-Ping Xu, Yan Liu, Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China

Zhen-Ping Fan, Department of The Fifth Cadre Health Care, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Geriatric Diseases, Beijing 100039, China

Wen-Hui Liu, Department of Gastroenterology, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Geriatric Diseases, Beijing 100853, China

Dong Ji, Chun Chen, Jun Zhao, Senior Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China

Co-first authors: Lan-Lan Si and Zhen-Ping Fan.

Co-corresponding authors: Jun Zhao and Yan Liu.

Author contributions: Liu Y and Zhao J substantially contributed to the conception and design of the work, played important and indispensable roles in the article as the co-corresponding authors; Si LL, Fan ZP, and Liu WH contributed to the acquisition, analysis, and interpretation of study data; Chen RJ, Chen XY, Ji D, Li Le, Chen C, Liao H and Wang J participated in the collection of patient samples and clinical information analysis; Xu DP, Si LL, Chen RJ, Zhao J, and Liu Y contributed to drafting the manuscript or revising it critically for important intellectual content; all authors reviewed and approved the final version of the manuscript.

Supported by The National Natural Science Foundation of China, No. 82470632.

Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Beijing 302 Hospital (Approved Number: FRM-EC-018-02-V2.0).

Conflict-of-interest statement: All authors declare that they have no competing interests.

Data sharing statement: The clinical patient data are not publicly available due to privacy protection restrictions, but can be accessed upon request by contacting the corresponding author (liuyan5360@163.com) and submitting a research proposal following approval by the Ethics Committee.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yan Liu, PhD, Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, No. 100 Xisihuan Middle Road, Beijing 100039, China. liuyan5360@163.com

Received: March 31, 2025
Revised: May 9, 2025
Accepted: July 16, 2025
Published online: August 27, 2025
Processing time: 149 Days and 20.3 Hours

Core Tip

Core Tip: Whether rtS106C+H126Y+D134E/rtS106C+H126Y+D134E+L269I (rtCYE/rtCYEI) mutations in the reverse-transcriptase region of hepatitis B virus (HBV) are associated with tenofovir resistance is controversial. The present study investigated many nucleoside/nucleotide analogues (NAs)-treated Chinese patients, focusing on the relationship between rtCYE/rtCYEI mutations and tenofovir resistance. We confirmed that rtCYE/rtCYEI mutations were rare (0.042%) in NAs-treated chronic HBV-infected patients and could appear in tenofovir treatment-naïve patients and remain sensitive to tenofovir. The effect of rtCYE/rtCYEI mutations on tenofovir susceptibility was limited. This study extends the current knowledge related to HBV resistance, which helps to explain the controversy and has clinical implications for resistance management.